Young Age as a Predictor of Chemotherapy Recommendation and Treatment in Breast Cancer: A National Cancer Database Study
Breast cancer, although the second most common malignancy in women in the United States, is rare in patients under the age of 40 y. However, this young patient population has high recurrence and mortality rates, with chemotherapy frequently used as adjuvant treatment. We aimed to determine whether age is an independent predictor of chemotherapy recommendation and subsequent treatment and the relationship to Oncotype Dx (ODX ) recurrence score (RS).
Source: Journal of Surgical Research - Category: Surgery Authors: Elaina Graham, Katie Bennett, Danielle Boselli, Anna Hecksher, Courtney Schepel, Richard L. White, Lejla Hadzikadic-Gusic Tags: Surgical Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Databases & Libraries | Study | Surgery | USA Health | Women